Daniel Sparks - Medical Properties Independent Director
| MPW Stock | USD 4.31 0.07 1.65% |
Director
Mr. Daniel Paul Sparks, Jr., is an Independent Director of Medical Properties Trust Inc. Mr. Sparks retired in January 2016 after a 32year career in the energy industry. He was Senior Vice President Resource Development for Energen Resources Corporation and served in various capacities with Energen since 1989, including Senior Vice President of Operations from 2006 until 2012. Mr. Sparks worked with Amoco Corporationrationration, a global chemical and oil company, in Texas and Louisiana prior to joining Energen. Prior to his retirement, Mr. Sparks helped Energen grow from a small regulated utility to a top 20 U.S. independent oil and gas exploration and production company. In his preretirement role, he was responsible for the forwardlooking strategy and implementation of valuing and developing the assets of Energen Resources Corporationrationration. Mr. Sparks was active in a number of organizations he is the former chairman of the New Mexico Oil and Gas Association, past advisor to the Gas Research Institute, a board member of the Independent Petroleum Association of America and past officer of the Society of Petroleum Engineers. He has authored a number of peerreviewed publications and holds a patent in oil and gas technology since 2014.
| Age | 57 |
| Tenure | 10 years |
| Address | 1000 Urban Center Drive, Birmingham, AL, United States, 35242-2225 |
| Phone | 205 969 3755 |
| Web | https://www.medicalpropertiestrust.com |
Medical Properties Management Efficiency
Return On Tangible Assets is likely to climb to -0.03 in 2024. Return On Capital Employed is likely to drop to 0 in 2024. At this time, Medical Properties' Total Assets are fairly stable compared to the past year. Other Assets is likely to climb to about 16.7 B in 2024, whereas Total Current Assets are likely to drop slightly above 1.3 B in 2024. Medical Properties' management efficiency ratios could be used to measure how well Medical Properties manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Roxanne Martino | Ventas Inc | 63 | |
| Charlotte Swafford | National Health Investors | 73 | |
| Roscoe Moore | Global Medical REIT | 76 | |
| John Abbott | Healthcare Realty Trust | 66 | |
| James Jobe | National Health Investors | 59 | |
| Peter Lyew | LTC Properties | 66 | |
| Kevin Jacobs | Omega Healthcare Investors | 47 | |
| Sean Nolan | Ventas Inc | 52 | |
| Alan Gardner | Community Healthcare Trust | 67 | |
| James Shelton | Ventas Inc | 66 | |
| Timothy Triche | LTC Properties | 75 | |
| Paula Crowley | Global Medical REIT | 66 | |
| Robert McCabe | National Health Investors | 70 | |
| Stephen Plavin | Omega Healthcare Investors | 60 | |
| Claire Gulmi | Community Healthcare Trust | 67 | |
| Edward Lowenthal | Omega Healthcare Investors | 75 | |
| Nancy Agee | Healthcare Realty Trust | 68 | |
| Burke Whitman | Omega Healthcare Investors | 64 | |
| Edward Braman | Healthcare Realty Trust | 64 | |
| Walter Rakowich | Ventas Inc | 63 | |
| Dana Hambly | National Health Investors | N/A | |
Management Performance
| Return On Equity | -0.39 | ||||
| Return On Asset | 0.003 |
Medical Properties Trust Leadership Team
Elected by the shareholders, the Medical Properties' board of directors comprises two types of representatives: Medical Properties inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medical. The board's role is to monitor Medical Properties' management team and ensure that shareholders' interests are well served. Medical Properties' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medical Properties' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Emmett McLean, Chief Operating Officer, Executive Vice President, Secretary | ||
| Caterina Mozingo, Independent Director | ||
| G Dawson, Independent Director | ||
| Edward Aldag, Co-Founder, Chairman, CEO and President and Chairman of Investment Committee | ||
| Michael Stewart, Lead Independent Director | ||
| Emily Murphy, Independent Director | ||
| Jamey Ramsey, Managing Tax | ||
| Charles Lambert, Treasurer VP | ||
| Steven CPA, Executive Founder | ||
| Steven Hamner, Chief Financial Officer, Executive Vice President, Director | ||
| Andrew CFA, Senior Communications | ||
| Daniel Sparks, Independent Director | ||
| Larry Portal, Senior CEO | ||
| Rosa Hooper, Assistant Operations | ||
| Tim Berryman, Director of Investor Relations | ||
| James Hanna, VP Officer | ||
| Elizabeth Pitman, Independent Director | ||
| R Hamner, Chief Financial Officer, Executive Vice President, Director | ||
| Lucas Savage, VP Acquisitions | ||
| C Thompson, Independent Director |
Medical Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medical Properties a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.39 | ||||
| Return On Asset | 0.003 | ||||
| Operating Margin | 0 % | ||||
| Current Valuation | 11.66 B | ||||
| Shares Outstanding | 600.4 M | ||||
| Shares Owned By Insiders | 13.37 % | ||||
| Shares Owned By Institutions | 65.41 % | ||||
| Number Of Shares Shorted | 222.18 M | ||||
| Price To Earning | 13.88 X | ||||
| Price To Book | 0.48 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Medical Stock Analysis
When running Medical Properties' price analysis, check to measure Medical Properties' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Properties is operating at the current time. Most of Medical Properties' value examination focuses on studying past and present price action to predict the probability of Medical Properties' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Properties' price. Additionally, you may evaluate how the addition of Medical Properties to your portfolios can decrease your overall portfolio volatility.